Search clinical trials for: Node Positive

Total 13089 results

Peking University Third Hospital
Bayer

Not yet recruiting

Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study

Prostate Cancer

China
Region Skane

Recruiting

Mediastinal EBUS Cryobiopsy Study In Sweden (MECRIS)

Lymphoma | Lung Cancer | Tuberculosis | Sarcoidosis | Mediastinal Lymphadenopathy

Sweden
Fudan University

Recruiting

Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib (Rainbow)

Breast Cancer

China
Johns Hopkins University
United States Agency for International Development (USAID)

Not yet recruiting

Shortened Regimen for Drug-susceptible TB in Children (SMILE-TB)

Tuberculosis | Tuberculosis, Pulmonary | Mycobacterium Tuberculosis | Tuberculosis, Lymph Node

Uganda, South Africa, Mozambique, Indonesia, Zambia
Zhejiang Cancer Hospital

Recruiting

A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC

Esophageal Squamous Cell Carcinoma

China
Sohag University

Recruiting

Clinical Presentation, and Treatment Outcomes in Tuberculous Patients in Sohag Governorate

Tuberculosis

Egypt
Mridula George, MD

Recruiting

RADIANT: Pre-op Radiation With Abemaciclib and Letrozole

Breast Cancer

United States
Assiut University

Not yet recruiting

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Initially Node Positive Breast Cancer Patients, Could it Omit Axillary Dissection ?

Sentinel Lymph Node
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Breast Neoplasms

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer

Breast Neoplasms

China
University of Michigan Rogel Cancer Center

Recruiting

Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, Node Positive, HR+/HER2- Breast Cancer

Breast Cancer

United States
Affiliated Cancer Hospital of Shantou University...

Recruiting

Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Case Comprehensive Cancer Center

Not yet recruiting

Axillary Node Dissection w or w/o LVB in Node Positive Breast Cancer Patients

Node-positive Breast Cancer
Regina Elena Cancer Institute
Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Weizmann Institute... and other collaborators

Recruiting

Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus

Liquid Biopsy | Squamous Cell Carcinoma of the Oropharynx | Lymph Node Metastasis | Carcinomas of Unknown Primary Site | High-risk Human Papillomavirus Infection | Occult Tumor of the Head and Neck Area

Italy
Fudan University

Recruiting

EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer

HER2 Positive Early Breast Cancer

China
National Taiwan University Hospital

Recruiting

Applying Shear Wave Elastography for Adjunct Steroid on Tuberculous Lymphadenitis

Tuberculous Lymphadenitis

Taiwan
Yixing People's Hospital

Recruiting

Efficacy and Safety of Tirelizumab Plus Chemotherapy Versus Chemotherapy Alone in Patients With Lymph Node Positive Gastric Cancer After Surgery

Gastric Cancer

China
M.D. Anderson Cancer Center
GlaxoSmithKline

Recruiting

Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

Endometrial Cancer

United States
Assiut University

Not yet recruiting

Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy

Node-positive Breast Cancer
Ruijin Hospital

Recruiting

RapidPlan Models Establishment for Node-Positive Breast Cancer Treated With Hypofractionation Using Edge/Truebeam

Breast Cancer

China
Kliniken Essen-Mitte

Recruiting

TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes (SenTa2)

Breast Cancer | Node-positive Breast Cancer

Germany
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma

Perihilar Cholangiocarcinoma

China
The University of Hong Kong
Endomagnetics Ltd.

Recruiting

Magnetic Marker Localization for Occult Breast Cancer and Target Axillary Dissection in Node-positive Breast Cancer Post-neoadjuvant Chemotherapy (MaCTAD)

Breast Neoplasm | Chemotherapy Effect

Hong Kong
The First Affiliated Hospital of Zhengzhou University
BeiGene; Jiangsu Hengrui Pharmaceutical Co., Ltd.; RemeGen Co., Ltd.

Not yet recruiting

Study of Tislelizumab Combined With DisitamabVedotin and Pyrotinib Maleate in HER2-positive or Mutated Advanced Colorectal Cancer Who Failed Standard Therapy

HER2-positive or Mutated Advanced Colorectal Cancer
Gangnam Severance Hospital
Seoul National University

Recruiting

OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk (INTERSTELLAR)

Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive Tumor | Premenopausal Breast Cancer | Node-positive Breast Cancer

Korea, Republic of
University Health Network, Toronto

Recruiting

Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer (MOB-RT)

Prostate Cancer

Canada
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC; Astellas Pharma US, Inc.; Seagen Inc.

Recruiting

Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer

Urothelial Carcinoma

United States
Veronica Morgan Jones

Recruiting

Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer

Breast Cancer | Breast Carcinoma | HER2-negative Breast Cancer | Node-negative Breast Cancer

United States
Fudan University

Recruiting

Axillary Sentinel or Targeted Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy in Node-positive Breast Cancer

Breast Cancer Female

China
M.D. Anderson Cancer Center
AstraZeneca

Recruiting

A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder

Bladder Cancer | Urothelial Carcinoma

United States
Hospital Universitari de Bellvitge

Recruiting

ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer (ADARNAT)

Breast Cancer | Chemotherapy | Sentinel Lymph Node | Radiotherapy Side Effect | Axillary Lymph Nodes Dissection

Spain
Tianjin Medical University Cancer Institute and...

Recruiting

Pembrolizumab in Post Radical Operation ESCC Patients With Lymph Node Positive ( KEYSTONE-004 )

ESCC | Adjuvant Treatment | Lymph Node Positive | Pembrolizumab

China
Memorial Sloan Kettering Cancer Center

Recruiting

Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation

Breast Cancer

United States
Oreste Davide Gentilini
IBFM- Consiglio Nazionale delle Ricerche

Recruiting

Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI

Sentinel Lymph Node | Breast Cancer Female | Node-positive Breast Cancer

Italy
Second Affiliated Hospital, School of Medicine,...
Sun Yat-sen University; Peking University International Hospital; Zhejiang University

Not yet recruiting

TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN)

HER2-positive Breast Cancer | Brain Metastases

China
Universitaire Ziekenhuizen KU Leuven
KU Leuven; Stichting tegen Kanker

Recruiting

Dose De-escalation and Sentinel LN Mapping Driven Radiotherapy of Contralateral Neck in Ipsilateral Node Positive HNSCC (SEMIRAHN)

Squamous Cell Carcinoma of Head and Neck

Belgium
Jewish General Hospital
Quebec Breast Cancer Foundation

Recruiting

Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer (TADEN)

Sentinel Lymph Node | Breast Cancer Female | Lymph Node Metastases | Early-stage Breast Cancer | Axillary Metastases

Canada
M.D. Anderson Cancer Center

Recruiting

Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma (MelPORT)

Melanoma

United States
Dana-Farber Cancer Institute
Genentech, Inc.

Recruiting

A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer (ADEPT)

Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Breast Cancer | Invasive Carcinoma of the Breast | Node Negative Breast Cancer | Micrometastasis Breast Cancer

United States
Dr. Paul Buderath

Recruiting

European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III (PMMR)

Endometrial Cancer

Germany
Maastricht University Medical Center
Erasmus Medical Center; The Netherlands Cancer Institute

Recruiting

Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer (MINIMAX)

Breast Cancer | Neoadjuvant Therapy | Lymph Node Metastases

Netherlands
Peking University

Recruiting

CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NAC

HER2-positive Breast Cancer | Triple-negative Breast Cancer

China
Laura M. Spring, MD
Merck Sharp & Dohme LLC; Translational Breast Cancer Research Consortium; Breast...

Recruiting

Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)

Triple Negative Breast Cancer | Hormone Receptor Positive (HR+), HER2-negative Breast Cancer | Biopsy-proven, Positive Lymph Node(s)

United States
Martini-Klinik am UKE GmbH
University Hospital Hamburg, Institute of Tumor Biology

Recruiting

Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s) (ProsTone)

Prostate Cancer

Germany
The Netherlands Cancer Institute

Not yet recruiting

Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy (ASICS)

Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Sentinel Lymph Node
xuexin he

Not yet recruiting

Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer (SHERO)

HER2-positive Breast Cancer
University Hospitals of Derby and Burton NHS Foundation...

Recruiting

Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy (ATNEC)

Breast Cancer | Sentinel Lymph Node | Neoplasm, Breast

United Kingdom
Toralf Reimer, MD PhD
European Breast Cancer Reseach Association of Surgical Trialists; University... and other collaborators

Recruiting

Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NAST

Breast Cancer | Breast Cancer Female

Spain, Austria, Germany, Italy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-sen University

Recruiting

RecurIndex Guided Avoidance of Regional Nodal Irradiation for Node Positive Breast Cancer (RIGAIN)

Breast Cancer | Radiation

China
Parc de Salut Mar
GEICAM

Recruiting

MUltimodal Targeted Axillary Surgery (MUTAS)

Node-positive Breast Cancer

Spain

Search clinical trials for: Node Positive

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations